Pharmacology beyond the patient – The environmental risks of human drugs
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The presence of pharmaceuticals in the environment is a growing global concern and although environmental risk assessment is required for approval of new drugs in Europe and the USA, the adequacy of the current triggers and the effects-based assessments has been questioned. OBJECTIVE: To provide a comprehensive analysis of all regulatory compliant aquatic ecotoxicity data and evaluate the current triggers and effects-based environmental assessments to facilitate the development of more efficient approaches for pharmaceuticals toxicity testing. METHODS: Publicly-available regulatory compliant ecotoxicity data for drugs targeting human proteins was compiled together with pharmacological information including drug targets, Cmax and lipophilicity. Possible links between these factors and the ecotoxicity data for effects on, growth, mortality and/or reproduction, were evaluated. The environmental risks were then assessed based on a combined analysis of drug toxicity and predicted environmental concentrations based on European patient consumption data. RESULTS: For most (88%) of the of 975 approved small molecule drugs targeting human proteins a complete set of regulatory compliant ecotoxicity data in the public domain was lacking, highlighting the need for both intelligent approaches to prioritize legacy human drugs for a tailored environmental risk assessment and a transparent database that captures environmental data. We show that presence/absence of drug-target orthologues are predictive of susceptible species for the more potent drugs. Drugs that target the endocrine system represent the highest potency and greatest risk. However, for most drugs (>80%) with a full set of ecotoxicity data, risk quotients assuming worst-case exposure assessments were below one in all European countries indicating low environmental risks for the endpoints assessed. CONCLUSION: We believe that the presented analysis can guide improvements to current testing procedures, and provide valuable approaches for prioritising legacy drugs (i.e. those registered before 2006) for further ecotoxicity testing. For drugs where effects of possible concern (e.g. behaviour) are not captured in regulatory tests, additional mechanistic testing may be required to provide the highest confidence for avoiding environmental impacts.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
The role of ligand efficiency metrics in drug discovery
Hopkins, A. L., Keserü, G. M., Leeson, P. D., Rees, D. C., & Reynolds, C. H. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4163 · Cited by 1,181
Dilute Concentrations of a Psychiatric Drug Alter Behavior of Fish from Natural Populations
Brodin, T., Fick, J., Jonsson, M., & Klaminder, J. (2013) · Science · doi:10.1126/science.1226850 · Cited by 850 · cited 1×
“There is a growing concern regarding behavioural alterations that may affect wildlife populations (Brodin et al., 2013; Hellström et al., 2016; Klaminder et al., 2014; Rand-Weaver et al., 2013).”
BackgroundHuggett, D. B., Brooks, B. W., Peterson, B., Foran, C. M., & Schlenk, D. (2002) · Archives of Environmental Contamination and Toxicology · doi:10.1007/s00244-002-1182-7 · Cited by 407
Cited by
Pharmaceutical pollution of the world’s rivers
Wilkinson, J. L., Boxall, A. B. A., Kolpin, D. W., Leung, K. M. Y., Lai, R. W. S., Galbán-Malagón, C., Adell, A. D., Mondon, J., Metian, M., Marchant, R. A., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2113947119 · Cited by 1,633
Assessing City-Wide Pharmaceutical Emissions to Wastewater via Modelling and Passive Sampling
Zillien, C., Groenveld, T., Schut, O., Beeltje, H., Blanco-Ania, D., Posthuma, L., Roex, E., & Ragas, A. (2024) · Environment International · doi:10.1016/j.envint.2024.108524 · Cited by 13
Meade, E. B., Iwanowicz, L. R., Neureuther, N., LeFevre, G. H., Kolpin, D. W., Zhi, H., Meppelink, S. M., Lane, R. F., Schmoldt, A., Mohaimani, A., et al. (2023) · Science of The Total Environment · doi:10.1016/j.scitotenv.2022.159069 · Cited by 12
Metadata
- Authors
- Gunnarsson, L., Snape, J. R., Verbruggen, B., Owen, S. F., Kristiansson, E., Margiotta-Casaluci, L., Österlund, T., Hutchinson, K., Leverett, D., Marks, B., & Tyler, C. R.
- Venue
- Environment International
- Publisher
- Elsevier BV
- Published
- 2019-08
- Volume
- 129
- Pages
- 320-332
- ISSN
- 0160-4120 (ISSN-L)
- OpenAlex
- W2947526781
- Cited by
- 208
- References
- 4
- FWCI
- 5.25
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.